Literature DB >> 11122252

Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats.

Y M Huang1, J S Yang, L Y Xu, H Link, B G Xiao.   

Abstract

Dendritic cells (DC) can modulate the nature of immune responses in a stimulatory or tolerogenic fashion. Great attention has been given to the induction of immunity to tumour and infection. In this study, bone marrow-derived DC from healthy Lewis rats were pulsed in vitro with encephalitogenic myelin basic protein peptide 68-86 (MBP 68-86), and injected subcutaneously (1 x 106/rat) into normal Lewis rats. Upon observation of the rats pretreated in this way for 4 weeks, when no clinical signs of EAE occurred, these rats were immunized with MBP 68-86 and Freund's complete adjuvant. The pretreated rats failed to develop clinical EAE. This tolerance was associated with augmented proliferative responses, interferon-gamma secretion, inducible nitric oxide synthase (iNOS) expression and NO production. The frequency of apoptotic cells was increased in the rats receiving MBP 68-86-pulsed DC compared with unpulsed control DC. Few infiltrating inflammatory cells were observed in spinal cord sections from rats that had received MBP 68-86-pulsed DC. The data are compatible with the interpretation that MBP 68-86-pulsed DC induce tolerance to EAE possibly through up-regulation of iNOS expression and NO production, which mediate cell apoptosis, thereby reducing infiltration of inflammatory cells within the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122252      PMCID: PMC1905816          DOI: 10.1046/j.1365-2249.2000.01398.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  41 in total

1.  Mechanisms of recovery from experimental allergic encephalomyelitis induced with myelin basic protein peptide 68-86 in Lewis rats: a role for dendritic cells in inducing apoptosis of CD4+ T cells.

Authors:  B G Xiao; Y M Huang; L Y Xu; M Ishikawa; H Link
Journal:  J Neuroimmunol       Date:  1999-06-01       Impact factor: 3.478

Review 2.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

3.  Nitrergic mechanism of DC-mediated T-cell elimination.

Authors:  J E Downing; L Virág; M E Perry
Journal:  Immunol Today       Date:  1998-04

4.  Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro.

Authors:  U K Zettl; E Mix; J Zielasek; M Stangel; H P Hartung; R Gold
Journal:  Cell Immunol       Date:  1997-05-25       Impact factor: 4.868

5.  Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells.

Authors:  R E Toes; E I van der Voort; S P Schoenberger; J W Drijfhout; L van Bloois; G Storm; W M Kast; R Offringa; C J Melief
Journal:  J Immunol       Date:  1998-05-01       Impact factor: 5.422

6.  Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation.

Authors:  M Krasteva; J Kehren; F Horand; H Akiba; G Choquet; M T Ducluzeau; R Tédone; J L Garrigue; D Kaiserlian; J F Nicolas
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

7.  IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide.

Authors:  D O Willenborg; S A Fordham; M A Staykova; I A Ramshaw; W B Cowden
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

8.  Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE.

Authors:  W B Cowden; F A Cullen; M A Staykova; D O Willenborg
Journal:  J Neuroimmunol       Date:  1998-08-01       Impact factor: 3.478

9.  Expanding dendritic cells in vivo enhances the induction of oral tolerance.

Authors:  J L Viney; A M Mowat; J M O'Malley; E Williamson; N A Fanger
Journal:  J Immunol       Date:  1998-06-15       Impact factor: 5.422

10.  Human dendritic cell (DC)-based anti-infective therapy: engineering DCs to secrete functional IFN-gamma and IL-12.

Authors:  S S Ahuja; S Mummidi; H L Malech; S K Ahuja
Journal:  J Immunol       Date:  1998-07-15       Impact factor: 5.422

View more
  15 in total

1.  Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats.

Authors:  B G Xiao; Y M Huang; J S Yang; L Y Xu; H Link
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

2.  Autoantigen-specific protection of non-obese diabetic mice from cyclophosphamide-accelerated diabetes by vaccination with dendritic cells.

Authors:  T Krueger; U Wohlrab; M Klucken; M Schott; J Seissler
Journal:  Diabetologia       Date:  2003-08-20       Impact factor: 10.122

3.  Nitric oxide controls an inflammatory-like Ly6C(hi)PDCA1+ DC subset that regulates Th1 immune responses.

Authors:  Daniela Giordano; Chang Li; Mehul S Suthar; Kevin E Draves; Daphne Y Ma; Michael Gale; Edward A Clark
Journal:  J Leukoc Biol       Date:  2010-12-22       Impact factor: 4.962

Review 4.  Dendritic Cells As Inducers of Peripheral Tolerance.

Authors:  Courtney A Iberg; Andrew Jones; Daniel Hawiger
Journal:  Trends Immunol       Date:  2017-08-18       Impact factor: 16.687

5.  Dendritic cells exposed in vitro to TGF-beta1 ameliorate experimental autoimmune myasthenia gravis.

Authors:  D Yarilin; R Duan; Y-M Huang; B-G Xiao
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

6.  A GMCSF-neuroantigen fusion protein is a potent tolerogen in experimental autoimmune encephalomyelitis (EAE) that is associated with efficient targeting of neuroantigen to APC.

Authors:  J Lori Blanchfield; Mark D Mannie
Journal:  J Leukoc Biol       Date:  2010-03       Impact factor: 4.962

7.  Antigen presenting cells treated in vitro by macrophage colony-stimulating factor and autoantigen protect mice from autoimmunity.

Authors:  Yangtai Guan; Shuo Yu; Zhao Zhao; Bogoljub Ciric; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Neuroimmunol       Date:  2007-11-19       Impact factor: 3.478

8.  Mitomycin C-treated dendritic cells inactivate autoreactive T cells: toward the development of a tolerogenic vaccine in autoimmune diseases.

Authors:  Peter Terness; Thilo Oelert; Sandra Ehser; Jing Jing Chuang; Imad Lahdou; Christian Kleist; Florian Velten; Günter J Hämmerling; Bernd Arnold; Gerhard Opelz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

9.  Application of dendritic cells stimulated with Trichinella spiralis excretory-secretory antigens alleviates experimental autoimmune encephalomyelitis.

Authors:  L J Sofronic-Milosavljevic; I Radovic; N Ilic; I Majstorovic; J Cvetkovic; A Gruden-Movsesijan
Journal:  Med Microbiol Immunol       Date:  2013-01-11       Impact factor: 3.402

10.  Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE).

Authors:  Derek J Abbott; J Lori Blanchfield; David A Martinson; Sean C Russell; Najla Taslim; Alan D Curtis; Mark D Mannie
Journal:  BMC Immunol       Date:  2011-12-30       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.